Cytogenomic delineation and clinical follow-up of 10 Brazilian patients with Pallister-Killian syndrome
Carregando...
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Citação
MOLECULAR CYTOGENETICS, v.8, article ID 43, 7p, 2015
Resumo
Background: Pallister-Killian syndrome (PKS) is a sporadic genetic disorder caused by the presence of a tissue-specific mosaicism for isochromosome 12p - i(12) (p10) and is characterized by facial dysmorphism including coarse facies, upslanting palpebral fissures, bitemporal alopecia, pigmentary skin anomalies, developmental delay, hypotonia and seizures. Although typical clinical features of PKS commonly exist, clinicians often do not raise the possibility of this diagnosis. Results: We reviewed the medical records of 10 patients with confirmed PKS followed in our service (since 1990 to 2015). Age at diagnosis varied from prenatal to 3 years and clinical features were consistent with those described in the literature. In all patients, peripheral blood karyotypes were normal and cytogenomic study was performed in order to confirm the diagnosis. Three of these patients had PKS diagnosis confirmed by buccal smear MLPA. Conclusion: An early conclusion from our results demonstrated that MLPA on buccal smears is a good and non-invasive method to detect extra copies of 12p and should be considered as the first exam, before a skin biopsy for a fibroblast karyotype is performed.
Palavras-chave
MLPA, Buccal smear, Pallister-Killian syndrome, isochromosome 12p
Referências
- Candee MS, 2012, AM J MED GENET A, V158A, P3026, DOI 10.1002/ajmg.a.35567
- CormierDaire V, 1997, AM J MED GENET, V69, P166, DOI 10.1002/(SICI)1096-8628(19970317)69:2<166::AID-AJMG9>3.0.CO;2-N
- Dutra RL, 2012, BMC RES NOTES, V9, P13
- Filloux FM, 2012, EUR J MED GENET, V55, P367, DOI 10.1016/j.ejmg.2012.01.006
- Genevieve D, 2003, AM J MED GENET A, V116A, P90, DOI 10.1002/ajmg.a.10877
- Giordano L, 2012, EUR J PAEDIATR NEURO, V16, P636, DOI 10.1016/j.ejpn.2012.03.003
- Graham W, 1999, ARCH OPHTHALMOL-CHIC, V117, P1648
- Kostanecka A, 2012, AM J MED GENET A, V158A, P3018, DOI 10.1002/ajmg.a.35670
- Leube B, 2003, AM J MED GENET A, V123A, P296, DOI 10.1002/ajmg.a.20339
- Liehr T, 2008, BALK J MED GENET, V11, P65, DOI 10.2478/v10034-008-0023-z
- Liehr T, 2015, SMALL SUPERNUMERARY
- PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934
- Rooney D, 2001, HUMAN CYTOGENETICS C, V3rd
- SCHINZEL A, 1991, J MED GENET, V28, P122, DOI 10.1136/jmg.28.2.122
- Shen JD, 2010, CHINESE MED J-PEKING, V123, P3482, DOI 10.3760/cma.j.issn.0366-6999.2010.23.019
- Stalker HJ, 2006, AM J MED GENET A, V140A, P1950, DOI 10.1002/ajmg.a.31403
- Sugayama SM, 2000, PEDIATRIA SAO PAULO, V22, P255
- Tilton RK, 2014, AM J MED GENET A, V164, P1130, DOI 10.1002/ajmg.a.36413
- Van Opstal D, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-2
- Vogel I, 2009, AM J MED GENET A, V149A, P510, DOI 10.1002/ajmg.a.32681
- WENGER SL, 1990, AM J MED GENET, V35, P523, DOI 10.1002/ajmg.1320350416
- Wilkens A, 2012, AM J MED GENET A, V158A, P3002, DOI 10.1002/ajmg.a.35722